Leading Agrochemical Player Indogulf Cropsciences Files for IPO

Suspense crime, Digital Desk : The Indian agrochemical sector is set to see a new publicly listed company as Indogulf Cropsciences Limited has officially filed its Draft Red Herring Prospectus (DRHP) with the market regulator, SEBI, to launch its Initial Public Offering (IPO).The Delhi-based company, a significant player in manufacturing and distributing crop protection products, is looking to raise funds for expansion and to allow its existing promoters to sell a portion of their stake.Breaking Down the IPO OfferThe public issue is a combination of a Fresh Issue of new shares and an Offer for Sale (OFS) by existing shareholders.Fresh Issue: The company plans to issue new equity shares worth up to ₹80 crore. The capital raised from this portion will go directly to the company. Indogulf intends to use these funds primarily for financing capital expenditure to expand its manufacturing facilities and for its working capital requirements, signaling a clear plan for growth.Offer for Sale (OFS): The promoters and other selling shareholders will offload up to 6,242,100 equity shares. The proceeds from the OFS will go to the selling shareholders, not the company.Who is Indogulf Cropsciences?Founded in 1993, Indogulf Cropsciences has grown into a major force in the agrochemical industry. The company manufactures and sells a wide range of products crucial for modern agriculture, including:InsecticidesFungicidesHerbicidesPlant Growth RegulatorsWith a robust pan-India distribution network and a strong presence in international markets, the company exports its products to over 20 countries. This diversified revenue stream, combining domestic strength with global reach, makes it a noteworthy player in the sector.The IPO is being managed by DAM Capital Advisors and InCred Capital, who are the book-running lead managers for the issue. The filing of the DRHP is the first step; the launch date, price band, and other key details of the IPO will be announced after receiving approval from SEBI.